Publications and communications of Anne LAMPROYE

LAMBRECHT, C., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., AMICONE, C., Warling, O., Lamproye, A., Delwaide, J., MEURISSE, N., Honoré, P., Hustinx, R., Lovinfosse, P., & Detry, O. (March 2023). 18FDG PET scanner as a selection criterion in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 86 (1), 17.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., JORIS, J., Delwaide, J., & Detry, O. (August 2022). Impact of donor age over 70 years in donation after circulatory death liver transplantation: a 15 years of experience. Transplantation, 106 (8S), 73 (LB-O-15.

AMICONE, C., Ledoux, D., MEURISSE, N., Honoré, P., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., Warling, O., Lamproye, A., KABA, A., Joris, J., Delwaide, J., & Detry, O. (05 May 2022). IMPACT OF DONOR AGE OVER 70 YEARS IN DONATION AFTER CIRCULATORY DEATH LIVER TRANSPLANTATION : A 15 YEARS OF EXPERIENCE [Paper presentation]. Belgian Surgical Week 2022, Ostende, Belgium.

Detry, O., Troisfontaine, F., MEURISSE, N., Delwaide, J., LAMPROYE, A., WARLING, O., JADOUL, A., LOLY, C., & COLLIGNON, J. (May 2021). Prise en charge multidisciplinaire des tumeurs malignes primitives du foie. Revue Médicale de Liège, 76 (5-6), 519-524.

Schielke, A. A., Paolucci, M., MEURISSE, N., Vandermeulen, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (October 2019). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS. Transplant International, 32 (S2), 029 p165.

DETRY, O., MEURISSE, N., LAMPROYE, A., WARLING, O., Oger, A., Delwaide, J., & Honoré, P. (2019). Problematique de la transplantation hepatique chez le patient alcoolique. Revue Médicale de Liège, 74 (5-6), 332-335.

WARLING, O., Oger, A., LAMPROYE, A., BERNARD, V., MARTING, A., DETRY, O., Louis, E., & Delwaide, J. (2019). L'hepatite alcoolique aigue. Revue Médicale de Liège, 74 (5-6), 326-331.

Schielke, A. A., Paolucci, M., MEURISSE, N., VANDERMEULEN, M., LAMPROYE, A., DELWAIDE, J., JORIS, J., KABA, A., HONORE, P., & DETRY, O. (29 November 2018). A SINGLE CENTER EXPERIENCE WITH 157 CONTROLED DCD-LIVER TRANSPLANTATIONS [Paper presentation]. 14eme Congrès Francophone de Chirurgie Digestive et Hépato-Bilio-Pancréatique, Marne la Vallée, France.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (15 March 2018). Liver transplantation in Jehovah’s Witnesses: a single center-experience [Paper presentation]. Joint NTV-BTS Transplantation congress, Rotterdam, Netherlands.

VANDERMEULEN, M., MEURISSE, N., DAMAS, P., KABA, A., LAMPROYE, A., DELWAIDE, J., JORIS, J., HONORE, P., & DETRY, O. (January 2018). Liver transplantation in Jehovah's witnesses. Acta Gastro-Enterologica Belgica, 81 (1), 30.

Degré, D., Laleman, W., Verhelst, X., LAMPROYE, A., Vanwolleghem, T., Gustot, T., Starkel, P., Lanthier, N., Michielsen, P., DELWAIDE, J., Van Vlierberghe, H., Nevens, F., & Moreno, C. (March 2016). Multicenter Belgian experience of sofosbuvir medical need program in pre-and post-liver transplantation patients: safety and efficacy results. Acta Gastro-Enterologica Belgica, 79 (1), 15.

Detry, O., Govaerts, L., De Roover, A., VANDERMEULEN, M., MEURISSE, N., Malenga, BLETARD, N., Mbendi, C., LAMPROYE, A., Honoré, P., MEUNIER, P., Delwaide, J., & Hustinx, R. (14 March 2015). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World Journal of Gastroenterology, 21 (10), 3049-54. doi:10.3748/wjg.v21.i10.3049

Degre, D., Laleman, W., Verhelst, X., LAMPROYE, A., Vanwolleghem, T., Gustot, T., Starkel, P., Lanthier, N., Michielsen, P., DELWAIDE, J., Van Vlierberghe, H., Nevens, F., & Moreno, C. (March 2015). Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results. Acta Gastro-Enterologica Belgica, 78 (1), 03.

MEURISSE, N., DETRY, O., Govaerts, L., DE ROOVER, A., VANDERMEULEN, M., Malenga, S., BLETARD, N., Mbendi, C., LAMPROYE, A., HONORE, P., MEUNIER, P., Delwaide, J., & HUSTINX, R. (September 2014). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. Transplant International, 27 (S2), 18 (EP-17.

DETRY, O., Govaerts, L., BLETARD, N., MEURISSE, N., Verset, G., DE ROOVER, A., DELWAIDE, J., LAMPROYE, A., HONORE, P., & HUSTINX, R. (March 2014). Prognostic value of FDG PET/CT in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 77 (1), 08.

DETRY, O., MEURISSE, N., DELWAIDE, J., LAMPROYE, A., Bastens, B., Brixko, C., Putzeys, V., Servais, B., MEURISSE, M., DE ROOVER, A., & HONORE, P. (March 2014). Controlled DCD donation is part of the solution to liver graft shortage, regardless of donor age. Acta Gastro-Enterologica Belgica, 77 (1), 16.

LEDOUBLE, V., BECK, E., PETERS, P., LAMPROYE, A., & Louis, E. (2013). Thrombose portale étendue chez un patient sous anti-vitamine K. Revue Médicale de Liège, (68(7-8)), 382-6.

Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (July 2011). Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World Journal of Gastroenterology, 17 (25), 3069-72. doi:10.3748/wjg.v17.i25.3069

Ledinh, H., HANS, M.-F., MONARD, J., DELBOUILLE, M.-H., DE ROOVER, A., DELWAIDE, J., LAMPROYE, A., LAUWICK, S., Honoré, P., & DETRY, O. (March 2011). Donation after Cardiac Death increases the number of liver grafts for liver transplantation. Acta Gastro-Enterologica Belgica, 74 (1), 10.

LOLY, J., GERARD, C., VAIRA, D., LAMPROYE, A., Bastens, B., Servais, B., Wain, E., Bataille, C., & DELWAIDE, J. (March 2011). Evolution over a 15 year period of the epidemiological profile of 2884 newly diagnosed HCV patients in Belgium. Acta Gastro-Enterologica Belgica, 74, 50.

Delwaide, J., Lamproye, A., & Belaiche, J. (May 2010). Défis pour réduire la mortalité liée à l'hépatite C: améliorer l'accessibilité au traitement et l'observance thérapeutique. Revue Médicale de Liège, 65 (5-6), 354-357.

Detry, O., Delwaide, J., Deroover, A., Meunier, P., Lamproye, A., Honore, P., & Polus, M. (March 2009). L’étude du mois. Traitement de l’hépatocarcinome au stade palliatif par Sorafenib (Nexavar) :Résultats de l’étude SHARP (Sorafenib Hepatocarcinoma Assessment Randomized Protocol). Revue Médicale de Liège, 64 (3), 168-170.

Detry, O., Seydel, B., Veys, C., De Roover, A., Hans, M.-F., Delbouille, M.-H., Monard, J., Delwaide, J., Lamproye, A., Lauwick, S., Damas, P., Damas, F., Squifflet, J.-P., & Meurisse, M. (January 2009). Results of liver transplantation from controlled donation after cardiac death (DCD) donors: a single center experience. Acta Gastro-Enterologica Belgica, 72 (1), 25.

Detry, O., Seydel, B., Veys, C., De Roover, A., Hans, M.-F., Delbouille, M.-H., Monard, J., Delwaide, J., Lamproye, A., Joris, J., Kaba, A., Lauwick, S., Damas, P., Damas, F., Squifflet, J.-P., Honore, P., & Meurisse, M. (December 2008). 5 ans d’expérience monocentrique de transplantation hépatique avec des donneurs à cœur arrêté de catégorie 3 de Maastricht [Paper presentation]. 4ème Congrès Annuel de la Société Francophone de Chirurgie Digestive et Hépatobiliaire, Paris, France.

Detry, O., De Roover, A., Coimbra Marques, C., Detroz, B., Delwaide, J., Kaba, A., Polus, M., Lamproye, A., Joris, J., Belaiche, J., Meurisse, M., & Honore, P. (2007). Actualites en chirurgie et transplantation hepatique. Revue Médicale de Liège, 62 (5-6, May-Jun), 310-6.

Lamproye, A., Belaiche, J., & Delwaide, J. (2007). Le Fibroscan: une nouvelle méthode d’évaluation non invasive de la fibrose hépatique. Revue Médicale de Liège, 62 Spec No, 68-72.

Delwaide, J., Giet, D., Lamproye, A., & Belaiche, J. (2006). Mise au point d'une hyperferritinémie. Revue Médicale de Liège, 61 (5-6), 329-333.

Gerard, C., Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Sondag, D., Rorive, G., Belaiche, J., & Rentier, B. (1998). Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients? Vox Sanguinis, 75 (1), 77-77. doi:10.1046/j.1423-0410.1998.7510077.x

Weekers, L., Biessaux, Y., Lamproye, A., Krzesinski, J.-M., & Demonty, J. (August 1997). La néphropathie épidémique a Hantavirus. Revue Médicale de Liège, 52 (8), 515-519.

Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Belaiche, J., SondagThull, D., & Rentier, B. (1997). Hepatitis G virus (HGV) prevalence in a Belgian population of chronic hemodialyzed patients. Gut, 41 (Suppl. 3), 129-A130.

Louis, E., Franchimont, D., Deprez, M., Lamproye, A., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (1996). Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. International Archives of Allergy and Immunology, 109 (1), 21-6. doi:10.1159/000237227

Louis, E., Franchimont, D., Lamproye, A., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (September 1995). Systemic Immune Response after Rectocolonic Administration of Ovalbumin in Mice. International Archives of Allergy and Immunology, 108 (1), 19-23. doi:10.1159/000237112

Louis, E., Louis, R., Drion, V., Bonnet, V., Lamproye, A., Radermecker, M., & Belaiche, J. (1995). Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy, 50 (9), 729-33. doi:10.1111/j.1398-9995.1995.tb01214.x